Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic sclerosis and cancer].

E Levrat1, G Waeber

  • 1Service de Médecine Interne, Département de Médecine, CHUV, Lausanne. levratemmanuel@hotmail.com

Praxis
|June 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.

Thrombosis research·2017
Same author

Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study.

Psychological medicine·2017
Same author

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.

PloS one·2017
Same author

Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus.

PloS one·2017
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Systemic sclerosis patients with esophageal issues like dysphagia may experience delayed cancer diagnosis. This case highlights the need to investigate potential links between systemic sclerosis and cancer risk.

Area of Science:

  • Gastroenterology and Rheumatology

Background:

  • Systemic sclerosis is a connective tissue disease characterized by skin induration and potential organ involvement.
  • Gastrointestinal manifestations, including esophageal dysmotility, are common in systemic sclerosis.
  • Esophageal symptoms can mimic or mask other serious conditions, potentially delaying diagnosis.

Observation:

  • A patient with long-standing systemic sclerosis presented with persistent heartburn and dysphagia.
  • These gastrointestinal symptoms were closely monitored but ultimately delayed the diagnosis of gastric adenocarcinoma.
  • The case underscores the diagnostic challenges posed by overlapping symptoms in systemic sclerosis.

Findings:

  • The association between systemic sclerosis and an increased risk of certain cancers is an area of ongoing research.

Related Experiment Videos

  • Esophageal dysmotility in systemic sclerosis may contribute to delayed diagnosis of gastrointestinal malignancies.
  • This case highlights a critical need for vigilance in evaluating gastrointestinal symptoms in systemic sclerosis patients.

    • Implications:

    • Consideration of oncologic evaluation during the follow-up of systemic sclerosis patients may be warranted.
    • Improved diagnostic strategies are needed to differentiate between systemic sclerosis-related symptoms and early signs of cancer.
    • Further research into the cancer-systemic sclerosis association is crucial for optimizing patient management and outcomes.